The Evolution and Future of CAR T Cells for B-Cell Acute Lymphoblastic Leukemia

被引：31

作者：

Annesley, Colleen E. ^{[1
]}

Summers, Corinne ^{[1
]}

Ceppi, Francesco ^{[1
]}

Gardner, Rebecca A. ^{[1
]}

机构：

[1] Seattle Childrens Hosp, Seattle, WA 98105 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 2018年 / 103卷 / 04期

关键词：

CHIMERIC ANTIGEN RECEPTORS; CYTOKINE RELEASE SYNDROME; SUSTAINED REMISSIONS; CD19; THERAPY; CD8(+); CHILDREN; PERSISTENCE; MEMORY; CHAIN;

D O I：

10.1002/cpt.950

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Several CAR T designs with CD19 specificity have been associated with consistent responses in clinical trials with complete remission (CR) rates ranging from 70-90%. Relevant challenges remain to be addressed, such as production time, early loss of CAR T cells, relapse due to loss of the target antigen, and prevention of severe cytokine release syndrome and neurotoxicity. This review describes constructs, clinical trial results, side effects, and future direction of CAR T-cell therapy in B-ALL.

引用

页码：591 / 598

页数：8

共 50 条

[21] Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
Aldoss, I.
Bargou, R. C.
Nagorsen, D.
Friberg, G. R.
Baeuerle, P. A.
Forman, S. J.
LEUKEMIA, 2017, 31 (04) : 777 - 787
[22] Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
Safarzadeh Kozani, Pouya
Safarzadeh Kozani, Pooria
Rahbarizadeh, Fatemeh
FRONTIERS IN IMMUNOLOGY, 2021, 12
[23] Chimeric Antigen Receptor T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia
Tomuleasa, Ciprian
Fuji, Shigeo
Berce, Cristian
Onaciu, Anca
Chira, Sergiu
Petrushev, Bobe
Micu, Wilhelm-Thomas
Moisoiu, Vlad
Osan, Ciprian
Constantinescu, Catalin
Pasca, Sergiu
Jurj, Ancuta
Pop, Laura
Berindan-Neagoe, Ioana
Dima, Delia
Kitano, Shigehisa
FRONTIERS IN IMMUNOLOGY, 2018, 9
[24] Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
Mo, George
Wang, Hao-Wei
Talleur, Aimee C.
Shahani, Shilpa A.
Yates, Bonnie
Shalabi, Haneen
Douvas, Michael G.
Calvo, Katherine R.
Shern, Jack F.
Chaganti, Sridhar
Patrick, Katharine
Song, Young
Fry, Terry J.
Wu, Xiaolin
Triplett, Brandon M.
Khan, Javed
Gardner, Rebecca A.
Shah, Nirali N.
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[25] The influence of CRS and ICANS on the efficacy of anti-CD19 CAR-T treatment for B-cell acute lymphoblastic leukemia
Ma, Yuhan
Zhou, Hongyuan
Zhang, Jiaoli
Zhang, Qing
Li, Yujie
Xie, Ruiyang
Zhang, Bingpei
Shen, Ziyuan
Li, Ping
Liang, Aibin
Zhou, Keshu
Han, Lu
Hu, Yongxian
Xu, Kailin
Sang, Wei
Wang, Xiangmin
FRONTIERS IN IMMUNOLOGY, 2024, 15
[26] Prediction of severe CRS and determination of biomarkers in B cell-acute lymphoblastic leukemia treated with CAR-T cells
Wei, Zhenyu
Xu, Jiayu
Zhao, Chengkui
Zhang, Min
Xu, Nan
Kang, Liqing
Lou, Xiaoyan
Yu, Lei
Feng, Weixing
FRONTIERS IN IMMUNOLOGY, 2023, 14
[27] Clinical use of CAR T-cells in treating acute lymphoblastic leukemia
Korkmaz, Serdal
TRANSFUSION AND APHERESIS SCIENCE, 2023, 62 (02)
[28] The role of allogeneic HSCT after CAR T cells for acute lymphoblastic leukemia
Jacoby, Elad
BONE MARROW TRANSPLANTATION, 2019, 54 (Suppl 2) : 810 - 814
[29] An owner's manual for CD19 "CAR"-T cell therapy in managing pediatric and young adult B-cell acute lymphoblastic leukemia
Laetsch, Theodore W.
Yanik, Gregory A.
Boyer, Michael W.
Rheingold, Susan R.
BLOOD REVIEWS, 2021, 50
[30] Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell Therapy
Arya, Rahul
Barrett, David M.
Grupp, Stephan A.
Melenhorst, Jan Joseph
CANCER JOURNAL, 2021, 27 (02) : 151 - 158

← 1 2 3 4 5 →